S9 Ep28: FDA Approval Insights: Elranatamab in Relapsed/Refractory Multiple Myeloma
Sep 21, 2023
18:34
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr Nooka discusses the FDA approval of elranatamab in relapsed/refractory multiple myeloma, key data from MagnetisMM-3, and the evolving role of bispecific antibodies in the multiple myeloma treatment paradigm.
OncLive® On Air